Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spatial Proteomics Profiles of Adrenal Adenoma/Hyperplasia Leading to Primary Aldosterone

NCT05927961 is registered in ClinicalTrials.gov with Third Military Medical University as lead sponsor.

NCT NCT05927961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05927961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spatial Proteomics Profiles of Adrenal Adenoma/Hyperplasia Leading to Primary Aldosterone
Lead sponsor
Third Military Medical University
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2023
Completion date
May 25, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism due to adrenal hyperplasia (bilateral), primary aldosteronism due to aldosterone producing adenoma